Recurrent Soft Tissue Infections Associated With Burosumab Therapy in X-Linked Hypophosphatemic Rickets

X-linked hypophosphatemic rickets (XLH) is a genetic disorder characterized by elevated fibroblast growth factor 23 (FGF23), resulting in renal phosphate wasting and inadequate bone mineralization. Burosumab, a monoclonal antibody that inhibits FGF23 activity, has shown promise in improving renal ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Sean Ho, Passarella, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634627/
https://www.ncbi.nlm.nih.gov/pubmed/37954837
http://dx.doi.org/10.1210/jcemcr/luad120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634627/
https://www.ncbi.nlm.nih.gov/pubmed/37954837
http://dx.doi.org/10.1210/jcemcr/luad120

Ejemplares similares